View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Uncategorized
June 26, 2020

Major pharmaceutical markets are severely deficient in the diagnosis of dry eye syndrome

By Victoria Smith

Dry eye syndrome is an ailment induced by a lack of adequate tears, which are essential for supporting eye health and clear vision. It is a prevalent and often chronic issue occurring in middle-aged and elderly individuals. In the nine principal pharmaceutical markets, GlobalData epidemiologists found that almost two-thirds of all DES cases went undiagnosed in 2018.

The principal driver behind this conclusion is the lack of uniform diagnostic criteria or disease guidelines for the diagnosis of DES. Read more here.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology